E-cadherin/catenin complex in benign and malignant melanocytic lesions

Journal of Pathology

Volumn 186, Issue 4, 1998, Pages 350-355

  Silye, R ^a   Karayiannakis, A J ^a   Syrigos, K N ^a   Poole, S ^a   Van Noorden, S ^a   Batchelor, W ^a   Regele, H ^b   Sega, W ^b   Boesmueller, H ^b   Krausz, T ^a   Pignatelli, M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Krankenhaus der Barmherzigen Schwestern Linz   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CATENIN; UVOMORULIN;

ADULT; AGED; ARTICLE; CELL ADHESION; DIAGNOSTIC VALUE; FEMALE; GROWTH CURVE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MELANOCYTIC NEVUS; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SKIN BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; CADHERINS; CYTOSKELETAL PROTEINS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MELANOMA; MIDDLE AGED; NEOPLASM PROTEINS; NEVUS, PIGMENTED; SKIN; SKIN NEOPLASMS;

EID: 0032413528     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199812)186:4<350::AID-PATH181>3.0.CO;2-K     Document Type: Article

References (27)

1. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991; 251: 1451-1455.
2. Gumbiner BM, MeCrea PD. Catenins as mediators of the cytoplasmic functions of cadherins. J Cell Sci 1993; 17: 155-158.
3. Hinck L, Näthke IS, Papkoff J, Nelson WJ. Dynamics of cadherin/catenin complex formation: novel protein interactions and pathways of complex assembly. J Cell Biol 1994; 125: 1327-1340.
4. Ozawa M, Ringwald M, Kemler R. Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. Proc Natl Acad Sci USA 1990; 87: 4246-4250.
5. Hirano S, Kimoto N, Shimoyama Y, Hirohashi S, Takeichi M. Identification of a neural α-catenin as a key regulator of cadherin function and multicellular organization. Cell 1992; 70: 293-301.
6. Vleminckx K, Vakaet L Jr, Marcel M, Fiers W, Van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumour cells reveals an invasion suppressor role. Cell 1991; 66: 107-119.
7. Frixen UH, Behrens J, Sachs M, et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991; 113: 173-185.
8. Shimazui T, Schalken JA, Giroldi LA, et al. Prognostic value of cadherin-associated molecules (α-, β-, and γ-catenins and p120cas) in bladder tumors. Cancer Res 1996; 56: 4154-4158.
9. Jawhari A, Jordan S, Poole S, Browne P, Pignatelli M, Farthing MJG. Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. Gastroenterology 1997; 112: 46-54.
10. Hashizume R, Koizumi H, Ihara A, Ohta T, Uchikoshi T. Expression of β-catenin in normal breast tissue and breast carcinoma: a comparative study with epithelial cadherin and α-catenin. Histopathology 1996; 29: 139-146.
11. Eidelman S, Damsky CH, Wheelock MJ, Damjanov I. Expression of the cell-cell adhesion glycoprotein cell-CAM 120/80 in normal human tissues and tumors. Am J Pathol 1989; 135: 101-110.
12. Wheelock MJ, Jensen PJ. Regulation of keratinocyte intercellular junction organization and epidermal morphogenesis by E-cadherin. J Cell Biol 1992; 117: 415-425.
13. Tang A, Eller MS, Hara M, Yaar M, Hirohashi S, Gilchrist BA. E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro. J Cell Sci 1994; 107: 983-992.
14. Danen EH, de-Vries TJ, Morandini R, Ghanem GG, Ruiter DJ, van-Muijen GN. E-cadherin expression in human melanoma. Melanoma Res 1996; 6: 127-131.
15. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P. Stabilization of β-catenin by genetic defects in melanoma cell lines. Science 1997; 275: 1790-1792.
16. Mooi WJ, Krausz T. Common acquired melanocytic naevi. In: Mooi WT, Krausz T, eds. Biopsy Pathology of Melanocytic Disorders. London: Chapman and Hall, 1992; 56-105.
17. Clark WH Jr, Elder DE, Van Horn M. The biologic forms of malignant melanoma. Hum Pathol 1986; 17: 443-450.
18. Cowley GP, Smith ME. Cadherin expression in melanocytic naevi and malignant melanomas. J Pathol 1996; 179: 183-187.
19. Van der Wurff AAM, Arends JW, Van der Linden EPM, Ten Kate J, Bosman FT. L-CAM expression in lymph node and liver metastases of colorectal carcinomas. J Pathol 1994; 172: 177-181.
20. Cowley GP, Smith ME. Modulation of E-cadherin expression and morphological phenotype in the intravascular component of adenocarcinomas. Int J Cancer 1995; 60: 325-329.
21. Navarro P, Gomez M, Pizarro A, Gamalllo C, Quintanilla M, Cano A. A role for the E-cadherin cell-cell adhesion molecule during tumor progression of mouse epidermal carcinogenesis. J Cell Biol 1991; 115: 517-533.
22. Hynes RO, Lander AD. Contact and adhesive specificities in the associations, migrations, and targeting of cells and axons. Cell 1992; 68: 303-322.
23. Nakagawa S, Takeichi M. Neural crest cell-cell adhesion controlled by sequential and subpopulation-specific expression of novel cadherins. Development 1995; 121: 1321-1332.
24. Hoschuetzky H, Aberle H, Kemler R. β-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor. J Cell Biol 1994; 127: 1375-1380.
25. Kanai Y, Ochiai A, Shibata T, et al. c-erbB-2 gene product directly associates with β-catenin and plakoglobin. Biochem Biophys Res Commun 1995; 208: 1067-1072.
26. Rubinfeld B, Souza B, Albert I, Munemitsu S, Polakis P. The APC protein and E-cadherin form similar but independent complexes with α-catenin, β-catenin, and plakoglobin. J Biol Chem 1995; 270: 5549-5555.
27. Rodeck U. Growth factor independence and growth regulatory pathways in human melanoma development. Cancer Metastasis Rev 1993; 12: 219-226.